10.1002/chem.202002384
Chemistry - A European Journal
COMMUNICATION
W. Zhen, X. Li, Adv. Synth. Catal. 2013, 355, 353; h) N. Webb, S.
Marsden, S. Raw, Org. Lett. 2014, 16, 4718; i) K. Collins, F. Lied, F.
Glorius, Chem. Commun. 2014, 50, 4459; j) N. Semakul, K. Jackson, R.
Paton, T. Rovis, Chem. Sci. 2017, 8, 1015; k) T. Saiegh, H. Chédotal, C.
Meyer, J. Cossy, Org. Lett. 2019, 21, 8364; l) W. Kong, L. Finger, A.
Messinis, R. Kuniyil, J. Oliveira, L. Ackermann, J. Am. Chem. Soc. 2019,
141, 17198.
M. Yoshida, Y. Hashimotoa, H. Miyachi, Bioorg. Med. Chem. Lett.
2007,17,4895; e) D. Hamprecht, F. Micheli, G. Tedesco, A. Checchia, D.
Donati, M. Petrone, S. Terrenia, M. Wood, Bioorg. Med. Chem. Lett.
2007,17, 428; f) K. Speck, T. Magauer, Beilstein J. Org. Chem. 2013, 9,
2048.
[16] a) J. Briscoe, P.P. Therond, Nat. Rev. Mol. Cell Biol. 2013, 14, 416; b) G.
Carballo, J. Honorato, G. de Lopes, T. Spohr, Cell. Commun. Signal.
2018, 16, 11.
[5]
a) S. Rakshit, C. Grohmann, T. Besset, F. Glorius, J. Am. Chem. Soc.
2011, 133, 2350; b) Y. Su, K. Han, G. Song, X. Li, Org. Lett. 2010, 12,
5462; c) N. Guimond, I. Gorelsky, K. Fagnou, J. Am. Chem. Soc. 2011,
133, 6449; d) M. Presset, D. Oehlrich, F. Rombouts, G. Molander, Org.
Lett. 2013, 15, 1528; e) M. Wodrich, B. Ye, J. Gonthier, C. Corminboeuf,
N. Cramer, Chem. Eur. J. 2014, 20, 15409; f) T. Hyster, D. Dalton, T.
Rovis, Chem. Sci. 2015, 6, 254; g) E. Trifonova, N. Ankudinov, M. Kozlov,
M. Sharipov, Y. Nelyubina, D. Perekalin, Chem. Eur. J. 2018, 24, 16570;
h) J. Barber, S. Scales, M. Tran-Dubé, F. Wang, N. Sach, L. Bernier, M.
Collins, J. Zhu, I. McAlpine, R. Patman, Org. Lett. 2019, 21, 5689.
For enantioselective rhodium-catalyzed alkene annulation processes: a)
B. Ye, N. Cramer, Science 2012, 338, 504; b) K. Hyster, L. Knörr, T.
Ward, T. Rovis, Science 2012, 338, 500; c) Z. Jia, C. Merten, R. Gontla,
C. Daniliuc, A. Antonchick, H. Waldmann, Angew. Chem. Int. Ed. 2017,
56, 2429; d) E. Trifonova, N. Ankudinov, A. Mikhaylov, D. Chusov, Y.
Nelyubina, D. Perekalin, Angew. Chem. Int. Ed. 2018, 57, 7714.
a) K. Hyster, E. Ruhl, T. Rovis, J. Am. Chem. Soc. 2013, 135, 5364; For
enantioselective rhodium-catalyzed diazo compounds annulation
process: b) B. Ye, N. Cramer, Angew. Chem. Int. Ed. 2014, 53, 7896;
other examples on rhodium-catalyzed diazo compounds annulation
process: c) Z. Qi, S. Yu, X. Li, Org. Lett. 2016, 18, 700; d) T. Zhou, B.
Lia, B. Wang, Chem. Commun. 2016, 52, 14117; e) S. Guo, Li. Sun, F.
Wang, X. Zhang, X. Fan, J. Org. Chem. 2018, 83, 12034; f) S. Guo, L.
Sun, Y. Liu, N. Ma, X. Zhang, X. Fan, Org. Lett. 2019, 21, 4082.
a) F. Wang, G. Song, X. Li, Org. Lett. 2010, 12, 5430; b) C. Zhu, J. Falck,
Chem. Commun. 2012, 48, 1674; c) Y. Lu, H. Wang, J. Spangler, K.
Chen, P. Cui, Y. Zhao, W. Sun, J. Yu, Chem. Sci. 2015, 6, 1923; d) L.
Wang, X. Liu, J. Shen, Q. Chen, M. He, Chem. Asian. J. 2018, 13, 756;
e) S. Wang, C. Li, J. Leng, S. Bukhari, H. Qin, Org. Chem. Front. 2018,
5, 1411; f) B. Ramesh, M. Tamizmani, M. Jeganmohan, J. Org. Chem.
2019, 84, 4058.
[17] L. Kremer, E. Hennes, A. Brause, A. Ursu, L. Robke, H. Matsubayashi, Y.
Nihongaki, J. Flegel, I. Mejdrova, J. Eickhoff, M. Baumann, R. Nencka,
P. Janning, S. Kordes, H. Schöler, J. Sterneckert, T. Inoue, S. Ziegler, H.
Waldmann, Angew. Chem. Int. Ed. 2019, 58, 16617.
[18] S. Peukert, K. Miller-Moslin, ChemMedChem, 2010, 5, 500.
[19] X. Wu, S. Ding, Q. Ding, N. S. Gray, P. G. Schultz, J. Am. Chem. Soc.
2002, 124, 14520.
[6]
[7]
[8]
[9]
During the preparation of this manuscript, S.-L. You et al. independently
and simultaneously developed a series of new ligands that also enable
the formation of isoindolinones from aryl-hydroxamates and styrenes: W-
J. Cui, Z-J. Wu, Q. Gu, S-L. You, J. Am. Chem. Soc. 2020, 142, 7379.
[10] The only examples where ortho-substituted styrene was used in this
chemistry was presented in reference 5a, but only on the Heck-type
reaction.
[11] The decrease in regioselectivity can be attributed to the increase in acidity
of the ortho C-H bond. This is in accordance with what was also observed
by Rovis et.al (ref 7a).
[12] For the isolation of these compounds, see: a) E. Valencia, A. Freyer, M.
Shamma, V. Fajardo, Tetrahedron Lett. 1984, 25, 599; selected
examples on the synthesis of lennoxamine: b) A. Padwa, S. Beall, C.
Eidell, K. Worsencroft, J. Org. Chem. 2001, 66, 2414; b) J. Fuchs, R.
Funk, Org. Lett. 2001, 3, 3923; c) G. Kim, J. Kim, W. Kim, Y. Kim,
Tetrahedron Lett. 2003, 44, 8207; d) D. Comins, S. Schilling, Y. Zhang,
Org. Lett. 2005, 7, 95; e) S. Couty, C. Meyer, J. Cossy, Tetrahedron Lett.
2006, 47, 767.
[13] K. D. Hesp M. Stradiotto, ChemCatChem. 2010, 2, 1192.
[14] a) L. Xu, Q. Zhu, G. Huang, B. Cheng, Y. Xia, J. Org. Chem. 2012, 77,
3017; b) T. Piou, F. Romanov-Michailidis, M. Romanova-Michaelides, K.
E. Jackson, N. Semakul, T. D. Taggart, B. S. Newell, C. D. Rithner, R. S.
Paton, T. Rovis, J. Am. Chem. Soc. 2017, 139, 1296.
[15] a) R. Belliotti, W. Brink, S. Kesten, J. Rubin, D. Wustrow, K. Zoski, S.
Whetzel, A. Corbin, A. Pugsley T. Heffner L. Wise, Bioorg. Med. Chem.
Lett. 1998, 8, 1499; b) A. Mertens, H. Zilch B. König, W. Schafer, T. Poll
W. Kampe, H. Seidel, U. Leser, H. Leinert, J. Med. Chem. 1993, 36,
2526; c) T. Honma, K. Hayashi, T. Aoyama, N. Hashimoto, T. Machida,
K. Fukasawa, T. Z. Iwama, C. Ikeura, M. Ikuta, I. Suzuki-Takahashi, Y.
Iwasawa, T. Hayama, S. Nishimura, H. Morishima, J. Med. Chem. 2001,
44, 4615; d) S. Lee, C. Shinji, K. Ogura, M. Shimizu, S. Maeda, M. Sato,
6
This article is protected by copyright. All rights reserved.